| ASSET | MONTH | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | November 2025 | 22.47% |
Merck (MRK) | November 2025 | 13.99% |
AstraZeneca PLC ADR (AZN) | November 2025 | 11% |
AbbVie (ABBV) | November 2025 | 9.05% |
Philip Morris International (PM) | November 2025 | 8.18% |
Johnson & Johnson (JNJ) | November 2025 | 7.88% |
Alphabet Inc Class A (GOOGL) | November 2025 | 6.2% |
Coca-Cola (KO) | November 2025 | 6.03% |
Intuitive Surgical (ISRG) | November 2025 | 5.55% |
Berkshire Hathaway (BRK.B) | November 2025 | 5.12% |
Berkshire Hathaway (BRK.A) | November 2025 | 4.97% |
Walmart (WMT) | November 2025 | 4.46% |
Thermo Fisher Scientific (TMO) | November 2025 | 4.23% |
McDonald’s (MCD) | November 2025 | 3.92% |
Abbott Laboratories (ABT) | November 2025 | 3.56% |
Novartis AG ADR (NVS) | November 2025 | 3.44% |
Exxon Mobil (XOM) | November 2025 | 3.15% |
Royal Bank of Canada (RY) | November 2025 | 2.66% |
Cisco Systems (CSCO) | November 2025 | 2% |
Procter & Gamble (PG) | November 2025 | 0.55% |
Apple (AAPL) | November 2025 | 0.49% |
PepsiCo (PEP) | November 2025 | 0.32% |
T-Mobile US (TMUS) | November 2025 | 0.08% |
HSBC Holdings PLC ADR (HSBC) | November 2025 | -1.02% |
Shell PLC ADR (SHEL) | November 2025 | -1.18% |
Mega-cap stocks are treated as having a market cap of $200B+.
